(0.28%) 5 114.12 points
(0.35%) 38 372 points
(0.33%) 15 981 points
(-1.47%) $82.62
(5.67%) $2.03
(0.29%) $2 353.90
(0.27%) $27.61
(4.02%) $959.20
(-0.21%) $0.933
(-0.35%) $10.99
(-0.53%) $0.796
(1.68%) $93.42
3.21% INR 603.80
Live Chart Being Loaded With Signals
Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana...
Stats | |
---|---|
Dagens volum | 9 091.00 |
Gjennomsnittsvolum | 21 441.00 |
Markedsverdi | 6.58B |
EPS | INR14.06 ( 2023-09-30 ) |
Last Dividend | INR0.500 ( 2022-07-01 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -115.89 |
ATR14 | INR0.926 (0.15%) |
Volum Korrelasjon
Balaxi Pharmaceuticals Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
LAKSHVILAS.NS | 0.837 |
ASIANPAINT.NS | 0.829 |
KIRIINDUS.NS | 0.822 |
BGLOBAL.NS | 0.819 |
DIXON.NS | 0.802 |
DMART.NS | 0.801 |
10 Mest negative korrelasjoner | |
---|---|
DFMFOODS.NS | -0.833 |
TOUCHWOOD.NS | -0.827 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Balaxi Pharmaceuticals Korrelasjon - Valuta/Råvare
Balaxi Pharmaceuticals Økonomi
Annual | 2022 |
Omsetning: | INR3.36B |
Bruttogevinst: | INR1.34B (39.83 %) |
EPS: | INR45.81 |
FY | 2022 |
Omsetning: | INR3.36B |
Bruttogevinst: | INR1.34B (39.83 %) |
EPS: | INR45.81 |
FY | 2022 |
Omsetning: | INR2.79B |
Bruttogevinst: | INR837.92M (29.99 %) |
EPS: | INR47.66 |
FY | 2021 |
Omsetning: | INR2.31B |
Bruttogevinst: | INR591.85M (25.58 %) |
EPS: | INR38.14 |
Financial Reports:
No articles found.
Balaxi Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.500 | 2022-07-01 |
Last Dividend | INR0.500 | 2022-07-01 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | INR0.500 | -- |
Avg. Dividend % Per Year | 0.02% | -- |
Score | 0.4 | -- |
Div. Sustainability Score | 2.50 | |
Div.Growth Potential Score | 0.0536 | |
Div. Directional Score | 1.279 | -- |
Year | Amount | Yield |
---|---|---|
2022 | INR0.500 | 0.10% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TOUCHWOOD.NS | Dividend Junior | 2023-09-22 | Annually | 6 | 0.15% | |
PGIL.NS | Dividend Junior | 2023-09-01 | Annually | 17 | 1.08% | |
JINDALSAW.NS | Dividend Junior | 2023-06-13 | Annually | 22 | 1.62% | |
DEEPAKNTR.NS | Dividend Junior | 2023-07-27 | Annually | 14 | 0.25% | |
SKMEGGPROD.NS | Dividend Junior | 2023-08-30 | Sporadic | 21 | 0.95% | |
MGEL.NS | Dividend Junior | 2023-08-08 | Annually | 5 | 0.59% | |
HARSHA.NS | Dividend Junior | 2023-09-20 | Insufficient data to determine frequency | 2 | 0.09% | |
BDL.NS | Dividend Knight | 2023-09-20 | Semi-Annually | 7 | 1.17% | |
PTC.NS | Dividend Knight | 2023-09-20 | Annually | 21 | 6.06% | |
KDDL.NS | Dividend Junior | 2023-09-22 | Annually | 8 | 0.29% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0199 | 1.500 | -0.398 | -0.597 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.0309 | 1.500 | -1.454 | -2.18 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 31.60 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.82 | 2.00 | 8.73 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.82 | 2.00 | 8.09 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.424 | 1.000 | 6.26 | 6.26 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.161 | 1.000 | 8.77 | 8.77 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -120.40 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0309 | 2.50 | -0.935 | -2.18 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.82 | 2.00 | 8.73 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.82 | 2.00 | 8.73 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0149 | 1.000 | -2.13 | 0 | [0.1 - 0.5] |
Total Score | 0.0536 |
Balaxi Pharmaceuticals
Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.